1AC- Debris I-law AC 1NC- Xi Lashout REM PIC Case 1AR- Case DA PIC 2NR- DA Case 2AR- Case DA
Emory
3
Opponent: SR | Judge: Cale McCrary
1AC- Lunar heritage aff 1NC- T REM PIC Case 1AR- Case T PIC 2NR- T Case 2AR- Case T
Emory
6
Opponent: JK | Judge: Rachel Ding
1AC- Kant AC Debris Adv 1NC- Xi lashout DIB DA Kant Framing Case 1AR- Case Xi DIB 2NR- Xi Case 2AR- Case Xi
Harvard Westlake
2
Opponent: WL | Judge: Joseph Barquin
1AC- Cap bad AC 1NC- Xi lashout Rem PIC Framing Case 1AR- Case Framing PIC Condo Bad DA 2NR- PIC Condo good Case 2AR- Condo bad
Harvard Westlake
3
Opponent: NT | Judge: Julian Kuffour
1AC- Colonialism AC 1NC- Xi Lashout DA REM PIC Framing Case 1AR- Framing Case PIC DA 2NR- DA Framing Case 2AR- Framing Case DA
Heart of Texas
1
Opponent: MT | Judge: Elijah Smith
1AC- Covid meds aff w inequality contention WTO cred and US-China war 1NC- Innovation DA Covid CP WHO CP Case 1AR- Case contention 1 WHO CP CCP Theory Covid CP DA 2NR- WHO CP Theory Case 2AR- Case CP Theory
1AC- SV aff 1NC- Innovation DA Consult WHO Framing Case 1AR- Case Framing CP DA F 2NR- CP Framing Case 2AR- Case Framing CP
Meadows
4
Opponent: MT | Judge: Alex Baez
1AC- Covid inequality adv WTO cred adv US-China War adv 1NC- Innovation DA Consult WHO Distribution CP Case 1AR- Case Distribution Consult DA 2NR- Consult Case 2AR- Case Consult
Meadows
5
Opponent: KK | Judge: Leah Clark-Villanueva
1AC- Neo-colonialism AC 1NC- Innovation DA Sui generis CP Fishing Subsidies DA Framing Case 1AR- Framing Case CP Innovation Subsidies 2NR- CP Innovation Framing Case 2AR- Framing Case CP Innovation
Nano Nagle
1
Opponent: KZ | Judge: Lukas Krause
1AC- Human rights AC 1NC- WHO CP Innovation DA Case 1AR- Case CP DA 2NR- CP Case 2AR- Case CP
Nano Nagle
3
Opponent: DV | Judge: Patrick Fox
1AC- inequalitycovid AC 1NC- T-meds WHO CP Innovation DA Case 1AR- Case T CP DA 2NR- T 2AR- T
Palm Classic
2
Opponent: Marlborough SG | Judge: Dhruv Ahuja
1AC- Global Commons AC 1NC- Xi DA REM PIC Case Util case proper Cap good warming turn 1AR- AC NC 2NR- PIC Case 2AR- Case PIC
Palm Classic
4
Opponent: Claudia Taylor Johnson AP | Judge: Ben Erdmann
1AC- Disabled futurity K aff 1NC- TFW Framing impact 1AR- NC AC 2NR- TFW Framing Case 2AR- Case T Framing
To modify or delete round reports, edit the associated round.
Cites
Entry
Date
Contact info
Tournament: NA | Round: 1 | Opponent: NA | Judge: NA Hi, I'm Ava! Feel free to reach out for disclosure or anything else you need. Email: awegmann2024@ihs.immaculateheart.org Phone: (213)-604-0522 she/her
cites aren't working but everything is open-sourced
1/31/22
JanFeb - DA - Xi Lashout
Tournament: Harvard Westlake | Round: 2 | Opponent: WL | Judge: Joseph Barquin Xi is consolidating unprecedented political power – that’s only possible with strong PLA support Chang 21 (Gordon, columnist, author and lawyer, has given briefings at the National Intelligence Council, the CIA, and the State Department, JD from Cornell Law School) “China Is Becoming a Military State,” Newsweek, 1/14/2021 JL
AND
The plan alienates the PLA – they view space dominance as the linchpin of China’s legitimacy – specifically, public-private tech development is key Economic Times 20 (Economic Times, Indian daily newspaper, internally cites Dean Cheng, Senior Research Fellow at the Heritage Foundation and the Davis Institute for National Security and Foreign Policy, former analyst in the International Security and Space Program at the Office of Technology Assessment, BA in Politics from Princeton University) “China attempting to militarize space as it seeks to modernize its military power,” 8/31/2020 JL
AND
That factionalizes the CCP and emboldens challenges to Xi – the PLA is increasingly powerful and not unconditionally subservient Simpson 16 (Kurtis, Centre Director with Defence Research and Development Canada, has been conducting research on China’s leadership, Communist Party politics, the People’s Liberation Army and foreign policy for over 30 years,Master’s Degree and a Ph.D from York University, previously served as an intelligence analyst at the Privy Council Office and leader of the Asia Research Section at the Department of National Defence’s Chief Defence Intelligence (CDI) organization) “China’s Re-Emergence: Assessing Civilian-Military Relations In Contemporary Era – Analysis,” Eurasia Review, 12/21/2016 JL
AND
CCP instability collapses the international order – extinction Perkinson 12 (Jessica, MA in international affairs from American University) “The Potential for Instability in the PRC: How the Doomsday Theory Misses the Mark,” American University School of International Service, 2012 JL
AND
Independently, Xi will lash out to preserve cred in the SCS – US draw-in ensures extinction Mastro 20 (Oriana Skylar, Assistant Professor of Security Studies at Georgetown University's Edmund A. Walsh School of Foreign Service, Resident Scholar at the American Enterprise Institute) “Military Confrontation in the South China Sea,” Council on Foreign Relations, 5/21/2020 JL
Tournament: Damus | Round: 1 | Opponent: AV | Judge: Michelle Grant Democracy is a form of bourgeois politics designed to suppress the proletariat – it upholds the illusion that the exploited have a say in how they are ruled ICC 15 (The ICC was founded in January 1975 by different political groups which had arisen in the wake of the historic revival of the working class at the end of the 1960s that uses Marxism as effective weapon of the proletarian struggle for emancipation while at the same time reaffirming the communist political positions which have been settled once and for all by the experience of the workers' movement.) “Proletarian politics against bourgeois electoralism” International Communist Current, 3/15 BC
AND
The aff’s rhetoric of unions and strikes as a solutions to labor disputes reinstates forces of capitalism Eidlin 20 (Barry Eidlin, assistant professor of sociology at McGill University and a former head steward for UAW Local 2865.), “Why Unions Are Good — But Not Good Enough”, JACOBIN, https://www.jacobinmag.com/2020/01/marxism-trade-unions-socialism-revolutionary-organizing, 01.06.2020 SS
AND
The “right to strike” is a tactic of neoliberal legalism and gets circumvented. The state is thus able to decide legitimate parameters for violence and insulate itself from anticapitalist action. Crépon 19 – Marc Crépon is a professor of philosophy at the École Normale Supérieure, Paris. (“The Right to Strike and Legal War in Walter Benjamin’s “Toward the Critique of Violence”,” August 2019, pg. 252-253)
AND
Capitalism is unsustainable and causes extinction – resource scarcity, environmental degradation, war Trainer ’16 (Ted; 5/10/16; Conjoint Lecturer in the School of Social Sciences, University of New South Wales, leading proponent of de-growth and sustainability issues; Resilience; “Sustainability – The Simpler Way perspective”; http://www.resilience.org/articles/General/2016/07_July/Sustainability20The20Simpler20Way20Perspective.pdf; DOA: 7/15/17)
AND
The alternative is to reorient political organizing away from the electoral system – only the alt provides the invisibility needed to construct alternative imaginaries Araujo et al 17 (Erin, of the Memorial University of Newfoundland) Ferretti (Federico Ferretti, of the University College Dublin) Ince (Anthony, of Cardiff University) Mullenite (Joshua, Florida International University) Pickerill (Jenny, of the University of Sheffield) Rollo (Toby, of the University of British Columbia) White (Richard, Sheffield Hallam University) “Beyond Electoralism: Reflections on anarchy, populism, and the crisis of electoral politics” ACME, 12/20/2017 BC
11/6/21
SepOct - AC- Sui Generis CP
Tournament: Meadows | Round: 5 | Opponent: KK | Judge: Leah Clark-Villanueva 1NC- Off CP: Member nations of the World Trade Organization should establish a sui generis right for holders of traditional knowledge. That solves the aff by preventing biopiracy while ensuring indigenous communities can use IP as an economic bargaining chip Garcia 07 (Javier, attorney at Perkins Coie LLP in Seattle, Washington, J.D. from Gonzaga University School of Law and B.A. from the University of Redlands) “Fighting Biopiracy: The Legislative Protection of Traditional Knowledge,” Berkeley La Raza Law Journal,” 3/2007 JL
AND
It competes – the CP is anti-topical action IPTF 04 (International Intellectual Property Institute, not-for-profit 501 corporation that provides education and training on intellectual property) “Is a Sui Generis System Necessary?” 1/14/2004 JL
11/1/21
SepOct - CP- Consult WHO
Tournament: Jack Howe | Round: 3 | Opponent: KK | Judge: Anish Ramireddy 1NC v. Dougherty Valley KK
WHO says yes WHO 06 (World Health Organization, specialized agency of the United Nations responsible for international public health) “Public health, innovation and intellectual property rights,” Report of the Commission on Intellectual Property Rights, Innovation, and Public Health, 2006 JL
AND
Consultation displays strong leadership, authority, and cohesion among member states which are key to WHO legitimacy Gostin et al 15 (Lawrence O., Linda D. and Timothy J. O’Neill Professor of Global Health Law at Georgetown University, Faculty Director of the O’Neill Institute for National and Global Health Law, Director of the World Health Organization Collaborating Center on Public Health Law and Human Rights, JD from Duke University) “The Normative Authority of the World Health Organization,” Georgetown University Law Center, 5/2/2015 JL
AND
WHO is critical to disease prevention – it is the only international institution that can disperse information, standardize global public health, and facilitate public-private cooperation Murtugudde 20 (Raghu, professor of atmospheric and oceanic science at the University of Maryland, PhD in mechanical engineering from Columbia University) “Why We Need the World Health Organization Now More Than Ever,” Science, 4/19/2020 JL
AND
WHO diplomacy solves great power conflict Murphy 20 (Chris, U.S. senator from Connecticut serving on the U.S. Senate Foreign Relations Committee) “The Answer is to Empower, Not Attack, the World Health Organization,” War on the Rocks, 4/21/2020 JL
9/19/21
SepOct - CP- Consult WHO - Covid meds
Tournament: Heart of Texas | Round: 1 | Opponent: MT | Judge: Elijah Smith 1NC – Off CP: Member nations of the World Trade Organization should enter into a prior and binding consultation with the World Health Organization over reducing intellectual property protections for medicines. Member nations will support the proposal and adopt the results of consultation.
WHO says yes Kimball 5/7 (Spencer, news editor with CNBC.com) “WHO chief urges world to follow U.S. lead and support waiving Covid vaccine patent protections,” CNBC, 5/7/2021 JL
AND
Hoen 03 (Ellen T., researcher at the University Medical Centre at the University of Groningen, The Netherlands who has been listed as one of the 50 most influential people in intellectual property by the journal Managing Intellectual Property, PhD from the University of Groningen) "TRIPS, Pharmaceutical Patents and Access to Essential Medicines: Seattle, Doha and Beyond," Chicago Journal of International Law, 2003 JL However, subsequent resolutions of the World Health Assembly have strengthened the WHO’s mandate in
AND
access to drugs, local manufacturing capacity, and the development of new drugs
Consultation displays strong leadership, authority, and cohesion among member states which are key to WHO legitimacy Gostin et al 15 (Lawrence O., Linda D. and Timothy J. O’Neill Professor of Global Health Law at Georgetown University, Faculty Director of the O’Neill Institute for National and Global Health Law, Director of the World Health Organization Collaborating Center on Public Health Law and Human Rights, JD from Duke University) "The Normative Authority of the World Health Organization," Georgetown University Law Center, 5/2/2015 JL Members want the WHO to exert leadership, harmonize disparate activities, and set priorities
AND
Organization generously, grant it authority and flexibility, and hold it accountable.
WHO is critical to disease prevention – it is the only international institution that can disperse information, standardize global public health, and facilitate public-private cooperation Murtugudde 20 (Raghu, professor of atmospheric and oceanic science at the University of Maryland, PhD in mechanical engineering from Columbia University) "Why We Need the World Health Organization Now More Than Ever," Science, 4/19/2020 JL WHO continues to play an indispensable role during the current COVID-19 outbreak itself
AND
and trade restrictions. WHO coordinates and helps build capacity to implement IHR.
Extinction – defense is wrong Piers Millett 17, Consultant for the World Health Organization, PhD in International Relations and Affairs, University of Bradford, Andrew Snyder-Beattie, "Existential Risk and Cost-Effective Biosecurity", Health Security, Vol 15(4), http://online.liebertpub.com/doi/pdfplus/10.1089/hs.2017.0028 Historically, disease events have been responsible for the greatest death tolls on humanity.
AND
, and available vectors, could be modified as well.19-2
WHO diplomacy solves great power conflict Murphy 20 (Chris, U.S. senator from Connecticut serving on the U.S. Senate Foreign Relations Committee) "The Answer is to Empower, Not Attack, the World Health Organization," War on the Rocks, 4/21/2020 JL The World Health Organization is critical to stopping disease outbreaks and strengthening public health systems
AND
international anti-pandemic infrastructure without the World Health Organization at the center.
10/16/21
SepOct - CP- Consult WHO - TRIPS
Tournament: Nano Nagle | Round: 3 | Opponent: DV | Judge: Patrick Fox WHO says yes – it supports increasing the availability of generics and limiting TRIPS Hoen 03 (Ellen T., researcher at the University Medical Centre at the University of Groningen, The Netherlands who has been listed as one of the 50 most influential people in intellectual property by the journal Managing Intellectual Property, PhD from the University of Groningen) “TRIPS, Pharmaceutical Patents and Access to Essential Medicines: Seattle, Doha and Beyond,” Chicago Journal of International Law, 2003 JL
AND
Consultation displays strong leadership, authority, and cohesion among member states which are key to WHO legitimacy Gostin et al 15 (Lawrence O., Linda D. and Timothy J. O’Neill Professor of Global Health Law at Georgetown University, Faculty Director of the O’Neill Institute for National and Global Health Law, Director of the World Health Organization Collaborating Center on Public Health Law and Human Rights, JD from Duke University) “The Normative Authority of the World Health Organization,” Georgetown University Law Center, 5/2/2015 JL
AND
WHO is critical to disease prevention – it is the only international institution that can disperse information, standardize global public health, and facilitate public-private cooperation Murtugudde 20 (Raghu, professor of atmospheric and oceanic science at the University of Maryland, PhD in mechanical engineering from Columbia University) “Why We Need the World Health Organization Now More Than Ever,” Science, 4/19/2020 JL
AND
WHO diplomacy solves great power conflict Murphy 20 (Chris, U.S. senator from Connecticut serving on the U.S. Senate Foreign Relations Committee) “The Answer is to Empower, Not Attack, the World Health Organization,” War on the Rocks, 4/21/2020 JL
10/9/21
SepOct- CP - Distribution CP
Tournament: Meadows | Round: 4 | Opponent: MT | Judge: Alex Baez 1NC-Off CP: Member nations of the World Trade Organization should adopt the European Union’s proposal to:
Ensure that COVID-19 vaccines, treatments and their components can cross borders freely 2. Encourage producers to expand their production, while ensuring that those countries most in need of vaccines receive them at an affordable price 3. Facilitate the use of compulsory licensing within the WTO's existing Agreement on Trade-Related Aspects of Intellectual Property Rights Solves vaccine access but avoids innovation Brachmann 6/8 (Steve, contributor to IPWatchdog.com, Research on Point, and Main Street Host writing about technology and innovation) “EU Offers Alternative to COVID-19 IP Waiver That Supports Innovation and Addresses Supply Chain Problems,” IP Watchdog, 6/8/2021 JL
11/1/21
SepOct- DA - Innovation DA
Tournament: Jack Howe | Round: 2 | Opponent: CL | Judge: Lukas Krause 1NC – Off Biotech industry strong now. Cancherini et al. 4/30 (Laura, Engagement Manager @ McKinsey and Company, Joseph Lydon, Associate Partner @ McKinsey and Company, Jorge Santos Da Silva, Senior Partner at McKinsey and Company, and Alexandra Zemp, Partner at McKinsey and Company), "What’s ahead for biotech: Another wave or low tide?", McKinsey and Company, 4-30-2021, https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/whats-ahead-for-biotech-another-wave-or-low-tide~~ TDI As the pandemic spread across the globe in early 2020, biotech leaders were initially
AND
IP protections are key to innovation – recouping startup costs and high risk of failure Grabowski et al 15 (Henry, Professor of Economics, member of the faculty for the Health Sector Management Program, and Director of the Program in Pharmaceuticals and Health Economics at Duke University) "The Roles of Patents and Research And Development Incentives In Biopharmaceutical Innovation," Health Affairs, 2/2015 JL The essential rationale for patent protection for biopharmaceuticals is that long-term benefits in
AND
IP enables critical information sharing Simon 6/25 (Brenda, professor at California Western School of Law, research interests focus on how technological developments affect intellectual property and information law, former teaching fellow for the Law, Science and Technology LL.M. Program at Stanford Law School, and a research fellow in the Stanford Center for Law and the Biosciences, JD from UC Berkeley School of Law) "Patents, Information, and Innovation," Brooklyn Law Review, 6/25/2020 JL Patents play numerous roles in encouraging the exchange of information during the investment-seeking
AND
Biopharmaceutical innovation is key to prevent future pandemics and bioterror. Marjanovic and Feijao 20 (Sonja Marjanovic, Ph.D., Judge Business School, University of Cambridge. Carolina Feijao, Ph.D. in biochemistry, University of Cambridge; M.Sc. in quantitative biology, Imperial College London; B.Sc. in biology, University of Lisbon.) "How to Best Enable Pharma Innovation Beyond the COVID-19 Crisis," RAND Corporation, 05-2020, https://www.rand.org/pubs/perspectives/PEA407-1.html~~ TDI As key actors in the healthcare innovation landscape, pharmaceutical and life sciences companies have
9/19/21
SepOct- DA - Innovation DA
Tournament: Nano Nagle | Round: 1 | Opponent: KZ | Judge: Lukas Krause 1NC – Off Biotech industry strong now. Cancherini et al. 4/30 (Laura, Engagement Manager @ McKinsey and Company, Joseph Lydon, Associate Partner @ McKinsey and Company, Jorge Santos Da Silva, Senior Partner at McKinsey and Company, and Alexandra Zemp, Partner at McKinsey and Company), "What’s ahead for biotech: Another wave or low tide?", McKinsey and Company, 4-30-2021, https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/whats-ahead-for-biotech-another-wave-or-low-tide~~ TDI As the pandemic spread across the globe in early 2020, biotech leaders were initially
AND
IP protections are key to innovation – recouping startup costs and high risk of failure Grabowski et al 15 (Henry, Professor of Economics, member of the faculty for the Health Sector Management Program, and Director of the Program in Pharmaceuticals and Health Economics at Duke University) "The Roles of Patents and Research And Development Incentives In Biopharmaceutical Innovation," Health Affairs, 2/2015 JL The essential rationale for patent protection for biopharmaceuticals is that long-term benefits in
AND
IP enables critical information sharing Simon 6/25 (Brenda, professor at California Western School of Law, research interests focus on how technological developments affect intellectual property and information law, former teaching fellow for the Law, Science and Technology LL.M. Program at Stanford Law School, and a research fellow in the Stanford Center for Law and the Biosciences, JD from UC Berkeley School of Law) "Patents, Information, and Innovation," Brooklyn Law Review, 6/25/2020 JL Patents play numerous roles in encouraging the exchange of information during the investment-seeking
AND
Biopharmaceutical innovation is key to prevent future pandemics and bioterror. Marjanovic and Feijao 20 (Sonja Marjanovic, Ph.D., Judge Business School, University of Cambridge. Carolina Feijao, Ph.D. in biochemistry, University of Cambridge; M.Sc. in quantitative biology, Imperial College London; B.Sc. in biology, University of Lisbon.) "How to Best Enable Pharma Innovation Beyond the COVID-19 Crisis," RAND Corporation, 05-2020, https://www.rand.org/pubs/perspectives/PEA407-1.html~~ TDI As key actors in the healthcare innovation landscape, pharmaceutical and life sciences companies have
10/9/21
SepOct- DA - Innovation DA
Tournament: Meadows | Round: 2 | Opponent: RM | Judge: Rafael Sanchez 1NC – Off Biotech industry strong now. Cancherini et al. 4/30 (Laura, Engagement Manager @ McKinsey and Company, Joseph Lydon, Associate Partner @ McKinsey and Company, Jorge Santos Da Silva, Senior Partner at McKinsey and Company, and Alexandra Zemp, Partner at McKinsey and Company), "What’s ahead for biotech: Another wave or low tide?", McKinsey and Company, 4-30-2021, https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/whats-ahead-for-biotech-another-wave-or-low-tide~~ TDI As the pandemic spread across the globe in early 2020, biotech leaders were initially
AND
IP protections are key to innovation – recouping startup costs and high risk of failure Grabowski et al 15 (Henry, Professor of Economics, member of the faculty for the Health Sector Management Program, and Director of the Program in Pharmaceuticals and Health Economics at Duke University) "The Roles of Patents and Research And Development Incentives In Biopharmaceutical Innovation," Health Affairs, 2/2015 JL The essential rationale for patent protection for biopharmaceuticals is that long-term benefits in
AND
IP enables critical information sharing Simon 6/25 (Brenda, professor at California Western School of Law, research interests focus on how technological developments affect intellectual property and information law, former teaching fellow for the Law, Science and Technology LL.M. Program at Stanford Law School, and a research fellow in the Stanford Center for Law and the Biosciences, JD from UC Berkeley School of Law) "Patents, Information, and Innovation," Brooklyn Law Review, 6/25/2020 JL Patents play numerous roles in encouraging the exchange of information during the investment-seeking
AND
Biopharmaceutical innovation is key to prevent future pandemics and bioterror. Marjanovic and Feijao 20 (Sonja Marjanovic, Ph.D., Judge Business School, University of Cambridge. Carolina Feijao, Ph.D. in biochemistry, University of Cambridge; M.Sc. in quantitative biology, Imperial College London; B.Sc. in biology, University of Lisbon.) "How to Best Enable Pharma Innovation Beyond the COVID-19 Crisis," RAND Corporation, 05-2020, https://www.rand.org/pubs/perspectives/PEA407-1.html~~ TDI As key actors in the healthcare innovation landscape, pharmaceutical and life sciences companies have
10/31/21
SepOct- DA - Innovation DA mRNA
Tournament: Jack Howe | Round: 5 | Opponent: ED | Judge: Ben Cortez 1NC-Off Biotech industry strong now Cancherini et al. 4/30 (Laura, Engagement Manager @ McKinsey and Company, Joseph Lydon, Associate Partner @ McKinsey and Company, Jorge Santos Da Silva, Senior Partner at McKinsey and Company, and Alexandra Zemp, Partner at McKinsey and Company), “What’s ahead for biotech: Another wave or low tide?“, McKinsey and Company, 4-30-2021, https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/whats-ahead-for-biotech-another-wave-or-low-tide TDI
AND
Lack of IP protection makes medical innovation prohibitively risky and expensive Grabowski et al 15 (Henry, Professor of Economics, member of the faculty for the Health Sector Management Program, and Director of the Program in Pharmaceuticals and Health Economics at Duke University) “The Roles of Patents and Research And Development Incentives In Biopharmaceutical Innovation,” Health Affairs, 2/2015 JL
AND
MRNA solves a litany of diseases, but continued innovation is key Gupta 5/7 (Swati, vice president and head of emerging infectious diseases and scientific strategy at IAVI, a nonprofit scientific research organization that develops vaccines and antibodies for HIV, tuberculosis, emerging infectious diseases (including COVID-19) and neglected diseases, PhD and MPH from Yale University) “The Application and Future Potential of mRNA Vaccines,” Yale School of Public Health, 5/7/2021 JL
AND
Disease causes extinction – defense is wrong Piers Millett 17, Consultant for the World Health Organization, PhD in International Relations and Affairs, University of Bradford, Andrew Snyder-Beattie, “Existential Risk and Cost-Effective Biosecurity”, Health Security, Vol 15(4), http://online.liebertpub.com/doi/pdfplus/10.1089/hs.2017.0028
AND
Disease causes extinction – defense is wrong Piers Millett 17, Consultant for the World Health Organization, PhD in International Relations and Affairs, University of Bradford, Andrew Snyder-Beattie, “Existential Risk and Cost-Effective Biosecurity”, Health Security, Vol 15(4), http://online.liebertpub.com/doi/pdfplus/10.1089/hs.2017.0028
9/19/21
SepOct- DA - Innovation DA- mRNA
Tournament: Meadows | Round: 4 | Opponent: MT | Judge: Alex Baez 1NC-Off Biotech industry strong now Cancherini et al. 4/30 (Laura, Engagement Manager @ McKinsey and Company, Joseph Lydon, Associate Partner @ McKinsey and Company, Jorge Santos Da Silva, Senior Partner at McKinsey and Company, and Alexandra Zemp, Partner at McKinsey and Company), “What’s ahead for biotech: Another wave or low tide?“, McKinsey and Company, 4-30-2021, https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/whats-ahead-for-biotech-another-wave-or-low-tide TDI
AND
Lack of IP protection makes medical innovation prohibitively risky and expensive Grabowski et al 15 (Henry, Professor of Economics, member of the faculty for the Health Sector Management Program, and Director of the Program in Pharmaceuticals and Health Economics at Duke University) “The Roles of Patents and Research And Development Incentives In Biopharmaceutical Innovation,” Health Affairs, 2/2015 JL
AND
MRNA solves a litany of diseases, but continued innovation is key Gupta 5/7 (Swati, vice president and head of emerging infectious diseases and scientific strategy at IAVI, a nonprofit scientific research organization that develops vaccines and antibodies for HIV, tuberculosis, emerging infectious diseases (including COVID-19) and neglected diseases, PhD and MPH from Yale University) “The Application and Future Potential of mRNA Vaccines,” Yale School of Public Health, 5/7/2021 JL
AND
Disease causes extinction – defense is wrong Piers Millett 17, Consultant for the World Health Organization, PhD in International Relations and Affairs, University of Bradford, Andrew Snyder-Beattie, “Existential Risk and Cost-Effective Biosecurity”, Health Security, Vol 15(4), http://online.liebertpub.com/doi/pdfplus/10.1089/hs.2017.0028
AND
Disease causes extinction – defense is wrong Piers Millett 17, Consultant for the World Health Organization, PhD in International Relations and Affairs, University of Bradford, Andrew Snyder-Beattie, “Existential Risk and Cost-Effective Biosecurity”, Health Security, Vol 15(4), http://online.liebertpub.com/doi/pdfplus/10.1089/hs.2017.0028
10/31/21
SepOct- T - Nebel Meds
Tournament: Jack Howe | Round: 5 | Opponent: ED | Judge: Ben Cortez 1NC-Off Interpretation: medicines is a generic bare plural. The aff may not defend that member nations of the World Trade Organization reduce intellectual property protections for a subset of medicines. Nebel 19 Jake Nebel Jake Nebel is an assistant professor of philosophy at the University of Southern California and executive director of Victory Briefs. , 8-12-2019, "Genericity on the Standardized Tests Resolution," Briefly, https://www.vbriefly.com/2019/08/12/genericity-on-the-standardized-tests-resolution/ SM Both distinctions are important. Generic resolutions can’t be affirmed by specifying particular instances.
AND
-value meaning and standard expectations about what LD resolutions tend to mean.
It applies to medicines: Upward entailment test – spec fails the upward entailment test because saying that nations ought to reduce IPP for one medicine does not entail that those nations ought to reduce IPP for all medicines Adverb test – adding "usually" to the res doesn’t substantially change its meaning because a reduction is universal and permanent Vote neg: Semantics outweigh: T is a constitutive rule of the activity and a basic aff burden – they agreed to debate the topic when they came here Jurisdiction – you can’t vote aff if they haven’t affirmed the resolution It’s the only stasis point we know before the round so it controls the internal link to engagement – there’s no way to use ground if debaters aren’t prepared to defend it Limits – there are countless affs accounting for thousands of medicines – unlimited topics incentivize obscure affs that negs won’t have prep on – limits are key to reciprocal prep burden – potential abuse doesn’t justify foregoing the topic and 1AR theory checks PICs There are over 20,000 affs FDA 11/18 (U.S. Food and Drug Administration, federal agency of the Department of Health and Human Service) "Fact Sheet: FDA at a Glance," 11/18/2020 JL There are over 20,000 prescription drug products approved for marketing. FDA
AND
drug products. There are about 300 FDA-licensed biologics products.
Ground – spec guts core generics like innovation that rely on reducing IP for all medicines because individual medicines don’t affect the pharmaceutical industry broadly – also means there is no universal DA to spec affs TVA solves – read as an advantage to whole rez Paradigm issues: Drop the debater – their abusive advocacy skewed the debate from the start Competing interps – reasonability invites arbitrary judge intervention and a race to the bottom of questionable argumentation Fairness is a voter ¬– necessary to determine the better debater Education is a voter – why schools fund debate
9/19/21
SeptOct-CP-Consult WHO
Tournament: Jack Howe | Round: 2 | Opponent: CL | Judge: Lukas Krause 1NC – Off CP: Member nations of the World Trade Organization should enter into a prior and binding consultation with the World Health Organization over reducing intellectual property protections for medicines. Member nations will support the proposal and adopt the results of consultation. WHO says yes – it supports increasing the availability of generics and limiting TRIPS Hoen 03 (Ellen T., researcher at the University Medical Centre at the University of Groningen, The Netherlands who has been listed as one of the 50 most influential people in intellectual property by the journal Managing Intellectual Property, PhD from the University of Groningen) "TRIPS, Pharmaceutical Patents and Access to Essential Medicines: Seattle, Doha and Beyond," Chicago Journal of International Law, 2003 JL However, subsequent resolutions of the World Health Assembly have strengthened the WHO’s mandate in
AND
Consultation displays strong leadership, authority, and cohesion among member states which are key to WHO legitimacy Gostin et al 15 (Lawrence O., Linda D. and Timothy J. O’Neill Professor of Global Health Law at Georgetown University, Faculty Director of the O’Neill Institute for National and Global Health Law, Director of the World Health Organization Collaborating Center on Public Health Law and Human Rights, JD from Duke University) "The Normative Authority of the World Health Organization," Georgetown University Law Center, 5/2/2015 JL Members want the WHO to exert leadership, harmonize disparate activities, and set priorities
AND
WHO is critical to disease prevention – it is the only international institution that can disperse information, standardize global public health, and facilitate public-private cooperation Murtugudde 20 (Raghu, professor of atmospheric and oceanic science at the University of Maryland, PhD in mechanical engineering from Columbia University) "Why We Need the World Health Organization Now More Than Ever," Science, 4/19/2020 JL WHO continues to play an indispensable role during the current COVID-19 outbreak itself
AND
Extinction – defense is wrong Piers Millett 17, Consultant for the World Health Organization, PhD in International Relations and Affairs, University of Bradford, Andrew Snyder-Beattie, "Existential Risk and Cost-Effective Biosecurity", Health Security, Vol 15(4), http://online.liebertpub.com/doi/pdfplus/10.1089/hs.2017.0028 Historically, disease events have been responsible for the greatest death tolls on humanity.
AND
WHO diplomacy solves great power conflict Murphy 20 (Chris, U.S. senator from Connecticut serving on the U.S. Senate Foreign Relations Committee) "The Answer is to Empower, Not Attack, the World Health Organization," War on the Rocks, 4/21/2020 JL The World Health Organization is critical to stopping disease outbreaks and strengthening public health systems
9/19/21
SeptOct-CP-Consult WHO
Tournament: Meadows | Round: 2 | Opponent: RM | Judge: Rafael Sanchez 1NC – Off CP: Member nations of the World Trade Organization should enter into a prior and binding consultation with the World Health Organization over reducing intellectual property protections for medicines. Member nations will support the proposal and adopt the results of consultation. WHO says yes – it supports increasing the availability of generics and limiting TRIPS Hoen 03 (Ellen T., researcher at the University Medical Centre at the University of Groningen, The Netherlands who has been listed as one of the 50 most influential people in intellectual property by the journal Managing Intellectual Property, PhD from the University of Groningen) "TRIPS, Pharmaceutical Patents and Access to Essential Medicines: Seattle, Doha and Beyond," Chicago Journal of International Law, 2003 JL However, subsequent resolutions of the World Health Assembly have strengthened the WHO’s mandate in
AND
Consultation displays strong leadership, authority, and cohesion among member states which are key to WHO legitimacy Gostin et al 15 (Lawrence O., Linda D. and Timothy J. O’Neill Professor of Global Health Law at Georgetown University, Faculty Director of the O’Neill Institute for National and Global Health Law, Director of the World Health Organization Collaborating Center on Public Health Law and Human Rights, JD from Duke University) "The Normative Authority of the World Health Organization," Georgetown University Law Center, 5/2/2015 JL Members want the WHO to exert leadership, harmonize disparate activities, and set priorities
AND
WHO is critical to disease prevention – it is the only international institution that can disperse information, standardize global public health, and facilitate public-private cooperation Murtugudde 20 (Raghu, professor of atmospheric and oceanic science at the University of Maryland, PhD in mechanical engineering from Columbia University) "Why We Need the World Health Organization Now More Than Ever," Science, 4/19/2020 JL WHO continues to play an indispensable role during the current COVID-19 outbreak itself
AND
Extinction – defense is wrong Piers Millett 17, Consultant for the World Health Organization, PhD in International Relations and Affairs, University of Bradford, Andrew Snyder-Beattie, "Existential Risk and Cost-Effective Biosecurity", Health Security, Vol 15(4), http://online.liebertpub.com/doi/pdfplus/10.1089/hs.2017.0028 Historically, disease events have been responsible for the greatest death tolls on humanity.
AND
WHO diplomacy solves great power conflict Murphy 20 (Chris, U.S. senator from Connecticut serving on the U.S. Senate Foreign Relations Committee) "The Answer is to Empower, Not Attack, the World Health Organization," War on the Rocks, 4/21/2020 JL The World Health Organization is critical to stopping disease outbreaks and strengthening public health systems
10/31/21
SeptOct-CP-Fishing Subsidies
Tournament: Meadows | Round: 5 | Opponent: KK | Judge: Leah Clark-Villanueva 1NC-Off WTO is near consensus on fisheries subsidies – success will require continued focus, flexibility, and cooperation among members WTO 7/15 (World Trade Organization) “WTO members edge closer to fisheries subsidies agreement,” News and Events, 7/15/2021 JL
AND
IP disputes fragment WTO unity and trade off with subsidies negotiation Patnaik 3/12 (Priti, journalist in Geneva, Switzerland, master’s in Development Studies from The Graduate Institute in Geneva and a master’s in Business and Economic Reporting from New York University) “Could Vaccine Nationalism Spur Disputes At The WTO?” Geneva Health Files, 3/12/2021 JL
AND
Overfishing collapses biodiversity DUJS 12 (Dartmouth Undergraduate Journal of Science, official open access science journal of Dartmouth College, publishing original scientific research, multidisciplinary review articles, and science news) “The Threats of Overfishing: Consequences at the Commercial Level,” 3/11/2012 JL
AND
Continued biodiversity loss causes extinction Carrington 18 (Damian, the Guardian's Environment editor) "Humanity has wiped out 60 of a animal populations since 1970, report finds," The Guardian, 10/29/18 TDI
11/1/21
SeptOct-FW-Util
Tournament: Jack Howe | Round: 2 | Opponent: CL | Judge: Lukas Krause 1NC-Framing The standard is maximizing expected wellbeing First, pleasure and pain are intrinsically valuable. People consistently regard pleasure and pain as good reasons for action, despite the fact that pleasure doesn’t seem to be instrumentally valuable for anything. Moen 16 Ole Martin Moen, Research Fellow in Philosophy at University of Oslo “An Argument for Hedonism” Journal of Value Inquiry (Springer), 50 (2) 2016: 267–281 SJDI
AND
Moreover, only pleasure and pain are intrinsically valuable. All other values can be explained with reference to pleasure; Occam’s razor requires us to treat these as instrumentally valuable. Moen 16 Ole Martin Moen, Research Fellow in Philosophy at University of Oslo “An Argument for Hedonism” Journal of Value Inquiry (Springer), 50 (2) 2016: 267–281 SJDI
AND
Moral uncertainty means preventing extinction should be our highest priority. Bostrom 12 Nick Bostrom. Faculty of Philosophy and Oxford Martin School University of Oxford. “Existential Risk Prevention as Global Priority.” Global Policy (2012)
AND
Reducing the risk of extinction is always priority number one. Bostrom 12 Faculty of Philosophy and Oxford Martin School, University of Oxford., Existential Risk Prevention as Global Priority. Forthcoming book (Global Policy). MP. http://www.existenti...org/concept.pdf